Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for 60 Degrees Pharmaceuticals (SXTP) over the last 3 years, with Q3 2025 value amounting to $8739.0.

  • 60 Degrees Pharmaceuticals' Interest & Investment Income rose 12102.95% to $8739.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$70610.0, marking a year-over-year decrease of 10443.56%. This contributed to the annual value of $1.8 million for FY2024, which is 3120.62% up from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Interest & Investment Income stood at $8739.0 for Q3 2025, which was up 12102.95% from -$128602.0 recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Interest & Investment Income's 5-year high stood at $5.7 million during Q3 2023, with a 5-year trough of -$151995.0 in Q4 2023.
  • Its 3-year average for Interest & Investment Income is $801851.6, with a median of $14962.0 in 2024.
  • Within the past 5 years, the most significant YoY rise in 60 Degrees Pharmaceuticals' Interest & Investment Income was 12102.95% (2025), while the steepest drop was 95952.41% (2025).
  • 60 Degrees Pharmaceuticals' Interest & Investment Income (Quarter) stood at -$151995.0 in 2023, then skyrocketed by 110.27% to $15616.0 in 2024, then crashed by 44.04% to $8739.0 in 2025.
  • Its Interest & Investment Income was $8739.0 in Q3 2025, compared to -$128602.0 in Q2 2025 and $33637.0 in Q1 2025.